Roche Holding AG (TSX:ROG)

Market Cap	458.08B
Revenue (ttm)	108.88B
Net Income (ttm)	16.17B
Shares Out	n/a
EPS (ttm)	20.14
PE Ratio	28.33
Forward PE	16.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	18,199
Open	24.70
Previous Close	24.78
Day's Range	24.70 - 24.70
52-Week Range	18.42 - 24.78
Beta	n/a
RSI	69.39
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Other
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF